StriVectin Multi-Action Clear Daily Brightening & Retexturizing Toner Versus Farmacy Brighten Up 3% TXA Dark Spot Toner with Azelaic Acid + PHA

Research shows it can encourage your skin cells to turn over and renew by stimulating keratinocyte and fibroblast proliferation.

It also has mild keratolytic properties to help loosen and shed dead skin cells without being harsh.

Studies also suggest allantoin can help calm inflammation by dialing down some of the chemical signals your skin sends out when it is irritated.

This ingredient is typically used in the 0.1-0.5% range, and the FDA recognizes it as a skin protectant in OTC products up to 2%.

Overall, allantoin is a wonderful addition to most routines; it is stable across a wide pH range (~4-8), works well with other ingredients, and is considered non-sensitizing/non-irritating.

Fun fact: Allantoin is naturally occurring in comfrey root, beets, chamomile, and wheat sprouts. Our bodies even produce it as a byproduct of uric acid metabolism.

Propanediol is not likely to cause sensitivity and considered safe to use. It is derived from corn or petroleum with a clear color and no scent.

Unlike most brighteners that target tyrosinase (the enzyme that synthesizes melanin), TXA works further upstream. It basically blocks your cells from receiving the signal to produce pigment.

This makes it one of the rare actives that works on three pathways at once:

This makes it effective for treating melasma, post-inflammatory hyperpigmentation (PIH), and sun-induced dark spots.

The most effective cosmetic concentration sits between 2-5% and going higher doesn't boost results.

Side effects are generally mild; occasional irritation, flaking, or dryness have been reported at the start of use. Overall, this ingredient is pretty well tolerated, even by sensitive skin types.

Another perk of this ingredient is that it does not cause photosensitivity, so it's safe to use in the AM and PM.

"Does it actually penetrate?" is the part that gets argued about online and the honest answer from research + clinical trials at this time is "yes, but not easily."

TXA is a small molecule that loves water and carries both a positive and negative charge at the same time. Skin's outer layer is oily so a water-loving molecule like this has a hard time getting through it. Liu et al. 2021 showed that it doesn't really stick around well in the deeper layer where pigment-making cells actually live.

A 2025 paper puts it simply: penetration is poor and it depends heavily on how the product is formulated (Winn et al., J Cosmet Dermatol).

But "poor" isn't "none" and the research is fairly clear that topical TXA does something. A 2026 review that pooled results from multiple studies found it helped with moderate melasma but it didn't outperform hydroquinone. Some individual studies at 3% and 5% went head to head with hydroquinone and help up well.

So the fair takeaway is that it works, it's just slower and fussier about formulation than other actives (how the serum is built matters a lot).

There's real evidence here and it's not just clinic marketing. Reviews of microneedling plus TXA report less pigmentation, less melanin, and less redness (Zhang et al., Chinese Journal of Plastic and Reconstructive Surgery, 2024).

The most useful study compared 42 patients getting microneedling plus TXA against microneedling on its own; the group that got the acid saw much bigger improvement. This suggests the acid is pulling its weight and the needling isn't doing all the work.

Just two things worth flagging here:

Oral TXA also works well for melasma and gets used in clinics. However, it is a systemic drug with clotting-related risks and needs a prescription. Injections into the skin have also been studied with good results.

Neither is something a cosmetic product can do, but they help explain why so much attention goes into getting the topical version right.